References
- Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y - A novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 1982; 296: 659–660
- Dumont Y., Fournier A., Pierre S. St., Quirion R. Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I] [Leu31, Pro34] peptide YY and [125I] peptide YY (3–36) as selective Y1 and Y2 radioligands. J. Pharmacol. Exp. Ther. 1995; 272: 673–680
- Colmers W. F., Bleakman D. Effects of neuropeptide Y on the electrical properties of neurons. Trends Neurosci. 1994; 17: 373–379
- Beck-Sickinger A. G., Jung G. Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors. Biopolymers 1995; 37: 123–142
- Michel M. C., Beck-Sickinger A. G., Cox H., Doods H. N., Herzog H., Larhammer D., Quirion R., Schwartz T. W., Westfall T. XVI International union of pharmacology recommendations for the nomenclature of neuropeptide Y., peptide YY, and pancreatic polypeptide receptors (review). Pharmacol. Rev. 1998; 50: 143–150
- Jahns R., Siegmund C., Jahns V., Reilander H., Maidhof A., Muller-Esterl W., Lohse M. J., Boege F. Probing human betal- and beta2-adrenoceptors with domain-specific fusion protein antibodies. Eur. J. Pharmacol. 1996; 316: 111–121
- Strosberg A. D. Receptor-ligand interaction - A practical approach, E. C. Hulme. IRL Press, Oxford 1992; 19–36
- Wall S. J., Yasuda R. P., Hory F., Flagg S., Martin B. M., Ginns E. I., Wolfe B. B. Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain. Mol. Pharmacol. 1991; 40: 643–649
- Muller-Newen G., Kohne C., Keul R., Hemmann U., Muller-Esterl W., Wijdenes J., Brakenhoff J. P., Hart M. H., Heinrich P. C. Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing. Eur. J. Biochem. 1996; 236: 837–842
- Abd Alla S., Godovac-Zimmermann J., Braun A., Roscher A. A., Muller-Esterl W., Quitterer U. Structure of the bradykinin B2 receptors' amino terminus. Biochemistry 1996; 35: 7514–7519
- Van den Pol A. N., Romano C., Ghosh P. Metabotropic glutamate receptor mGluR5 subcellular distribution and developmental expression in hypothalamus. J. Comp. Neurol. 1995; 362: 134–150
- Westphal R. S., Backstrom J. R., Sandersbush E. Increased basal phosphorylation of the constitutively active serotonin 2c receptor accompanies agonist-mediated desensitization. Mol. Pharmacol. 1995; 48: 200–205
- Palmer T. M., Gettys T. W., Jacobson K. A., Stiles G. L. Desensitization of the canine A2a adenosine receptor: Deliniation of multiple processes. Mol. Pharmacol. 1994; 45: 1082–1094
- Bahouth S. W., Wang H., Malbon C. C. Immunological approaches for probing receptor structure and function. Trends Pharmacol. Sci. 1991; 12: 338–343
- Amati V., Cattaneo A., Werge T. M., Tramontano A. Identifying a putative common binding site shared by substance P receptor and an antisubstance P monoclonal antibody. Protein Eng. 1995; 8: 403–408
- Lämmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
- Zimmermann N., Beck-Sickinger A. G., Folkers G., Krickl S., Müller I., Jung G. Conformational and epitope mapping of herpes-simplex-virus type-1 thymidine kinase using synthetic peptide segments. Eur. J. Biochem. 1991; 200: 519–528
- Behrends H. W., Folkers G., Beck-Sickinger A. G. A new approach to secondary structure evaluation: Secondary structure prediction of porcine adenylate kinase and yeast guanylate kinase by CD spectroscopy of overlapping synthetic peptide segments. Biopolymers 1997; 41: 213–231
- Beck-Sickinger A. G. Structural characterization and binding sites of G-protein-coupled receptors. Drug Discovery Today 1996; 1: 502–513
- Wieland H. A., Eckard C. P., Doods H. N., Beck-Sickinger A. G. Probing of the Neuropeptide Y-Y1 receptor interaction with anti-receptor antibodies. Eur. J. Biochem. 1998, in press